In today’s global economy, the fight against financial crime is more critical than ever. Anti-Money Laundering (AML) certifications are essential for professionals seeking to advance their careers in ...

Fatigue is a key prognostic indicator for adverse outcomes in AML, ALL, and myelodysplastic syndromes. CAR T-cell therapy post-transplant shows a 48% complete remission rate in AML, though not ...

Academic-community partnerships can reduce patient travel burdens while maintaining high-quality cancer care, as demonstrated by successful high-dose cytarabine consolidation delivery. A flow ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

Money laundering is a massive global problem estimated at 2-5% of global GDP (up to $2 trillion annually). In response to the situation, regulatory authorities worldwide are developing stringent laws ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells, ...

AML fights financial crime by tracking and reporting suspicious crypto transactions. Know Your Customer (KYC) checks are a cornerstone of AML, verifying user identities. The Travel Rule mandates ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...

Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...